Drug Prices
The Senate Finance Committee today voted 19-9 to pass the Prescription Drug Pricing Reduction Act, legislation to reduce drug costs.
The AHA, AAMC and FAH agree with the Committee’s goal of reducing the price of drugs, and applaud many of the steps outlined in the description of the Chairman’s Mark of the Prescription Drug Pricing Reduction Act (PDPRA) of 2019. However, have serious concerns regarding the provisions that…
Senate Finance Committee Chairman Chuck Grassley, R-Iowa, and Ranking Member Ron Wyden, D-Ore., today released a description of the chairman’s mark, the Prescription Drug Pricing Reduction Act of 2019.
The Trump administration today withdrew a proposed rule that would eliminate the rebate safe harbor for pharmacy benefit managers under the federal anti-kickback statute, and create new safe harbors to protect price reductions at the point-of-sale and certain fees paid by drug makers for PBM…
Drug makers this week increased list prices for at least 104 different drugs, dosages or package sizes, with the average price increase 13.1%, according to an analysis of select drugs by Rx Savings Solutions.
The Senate Judiciary Committee today passed four bills aimed at lowering prescription drug costs and increasing competition.
The Senate Committee on Health, Education, Labor and Pensions today voted 20-3 to pass the Lower Health Care Costs Act (S.1895) – bipartisan legislation focused on reducing health care costs.
Senate Health, Education, Labor and Pensions Committee leaders today released a manager’s amendment to the Lower Health Care Costs Act of 2019 (S.1895) making several updates to the bill.
New resources available to assist with your advocacy efforts
Senate Health, Education, Labor and Pensions Committee leaders today released a manager’s amendment to the Lower Health Care Costs Act of 2019 (S.1895) making several updates to the bill.
The AHA today submitted comments on the revised version of the Lower Health Care Costs Act (S. 1895), legislation to prevent surprise medical bills, reduce prescription drug prices, improve transparency in health care, invest in public health and improve health information exchange.